Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/29/1998 | CA2258562A1 Process for the inactivation of genes which code for enzymes for the catabolism of phenyl acetate, plasmids involved in such process and strains transformed therewith |
10/29/1998 | CA2204213A1 Plant treatment process and apparatus |
10/28/1998 | EP0874057A2 Vector and mammalian cell line having improved productivity |
10/28/1998 | EP0874056A1 C3 plants expressing photosynthetic enzymes of C4 plants |
10/28/1998 | EP0874055A2 Method for the protection of plants against pathogens |
10/28/1998 | EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells |
10/28/1998 | EP0874053A2 3-Dehydroquinate synthase (aroB) |
10/28/1998 | EP0874052A2 Nucleic acid encoding a human protein phosphatase |
10/28/1998 | EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines. |
10/28/1998 | EP0874050A2 Integrin ligand ITGL-TSP |
10/28/1998 | EP0874049A1 Nucleic acid sequences of CIITA genes |
10/28/1998 | EP0874048A2 Human hedgehog protein |
10/28/1998 | EP0874047A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor |
10/28/1998 | EP0874046A1 A novel signal transduction factor and a gene encoding the same |
10/28/1998 | EP0874045A1 Novel dnas and process for producing proteins by using the same |
10/28/1998 | EP0873427A2 Process for detecting and quantifying nucleic acid molecules |
10/28/1998 | EP0873426A1 Method of detection of polymorphism and loss of heterozygosity in a lung tumor suppressor gene |
10/28/1998 | EP0873424A1 Metastasis inducing dna's |
10/28/1998 | EP0873422A2 Method for generating multiple double stranded nucleic acids |
10/28/1998 | EP0873421A1 DIAGNOSTIC METHOD AND KIT FOR DETERMINING Rh BLOOD GROUP GENOTYPE |
10/28/1998 | EP0873420A1 Thermophilic dna polymerases from thermotoga neapolitana |
10/28/1998 | EP0873413A1 A method for visually selecting transgenic plant cells or tissues by carotenoid pigmentation |
10/28/1998 | EP0873412A1 Plant adenylosuccinate lyase and dna coding therefor |
10/28/1998 | EP0873411A1 Improved mutants of (2,5-dkg) reductase |
10/28/1998 | EP0873410A1 Transgenic plants exhibiting altered flower colour and methods for producing same |
10/28/1998 | EP0873409A1 Equine rhinovirus 1 proteins |
10/28/1998 | EP0873408A1 Calcium binding proteolipid compositions and methods |
10/28/1998 | EP0873407A1 Apo-2 ligand |
10/28/1998 | EP0873406A2 Protein induced by deprenyl |
10/28/1998 | EP0873405A1 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
10/28/1998 | EP0873403A2 Novel dna glycosylases and their use |
10/28/1998 | EP0873400A1 Delivery of bioactive compounds to an organism |
10/28/1998 | EP0873399A1 Monoclonal lymphocytes and methods of use |
10/28/1998 | EP0873398A1 A method for in vivo production of a mutant library in cells |
10/28/1998 | EP0873360A1 Transforming growth factor alpha hiii |
10/28/1998 | EP0873354A1 Novel amp activated protein kinase |
10/28/1998 | EP0873353A1 IgG SEPARATION MEDIUM AND NOVEL PROTEIN A VARIANT |
10/28/1998 | EP0873350A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
10/28/1998 | EP0873349A1 Endothelial-monocyte activating polypeptide iii |
10/28/1998 | EP0873141A1 Compositions and methods for therapeutic use |
10/28/1998 | EP0873138A2 Improved pharmaceutical compositions |
10/28/1998 | EP0873135A1 Peanut allergens and methods |
10/28/1998 | EP0873049A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
10/28/1998 | EP0774959B1 A liposomal delivery system for biologically active agents |
10/28/1998 | EP0759931B1 An enzymatic process for producing a desired protein from an amino terminal extended protein |
10/28/1998 | EP0736105A4 Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
10/28/1998 | EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
10/28/1998 | EP0349578B2 Organism carrying a Single Chain Antibody Domain at its surface. |
10/28/1998 | CN1197483A Inducible herbicide resistance |
10/28/1998 | CN1197482A Improved integration of exogenous DNA delivered to eukaryoltic cells |
10/28/1998 | CN1197481A Inhibition of cell respiration and prodn. of male sterile plants |
10/28/1998 | CN1197480A Device 'Biotron-Tszyan 1' for transmitting a natural information flow to a biological object |
10/28/1998 | CN1197461A Truncated glial cell line-derived neurotrophic factor |
10/28/1998 | CN1197394A Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
10/28/1998 | CN1197393A Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
10/28/1998 | CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes |
10/28/1998 | CA2231746A1 A human sodium dependent phosphate transporter (ipt-1) |
10/27/1998 | US5827935 Chimeric tRNAlys -ribozyme molecules |
10/27/1998 | US5827826 Compositions of human endothelial cell growth factor |
10/27/1998 | US5827817 P-selectin ligand protein |
10/27/1998 | US5827816 Bactericide for gram-negative bacteria infection; a polypeptide with a cysteine at position 132 replaced by different amino acid |
10/27/1998 | US5827742 Method of selecting pluripotent hematopioetic progenitor cells |
10/27/1998 | US5827739 Recombinant DNA sequences, vectors containing them and method for the use thereof |
10/27/1998 | US5827737 Stable drosophila cell line |
10/27/1998 | US5827733 Growth differentiation factor-8 (GDF-8) and polynucleotides encoding same |
10/27/1998 | US5827731 Anticoagulant |
10/27/1998 | US5827730 Protein containing atleast one amino acid glycine subsituted by arginine at position 972 and such substitution interferes with signal transduction through insulin receptor substrate-1 |
10/27/1998 | US5827726 An isolated hybridized gene; encoded enzyme can be used developing drugs as enzyme inhibitor or promote the activities of kinase, suppress the gene expression, control the cell differentiation, treating cancer |
10/27/1998 | US5827724 Baker's yeasts having a low temperature inactivation property |
10/27/1998 | US5827723 Neutralizing monoclonal antibody 0.5β which binds an epitope located within the region of amino acids 308-331 of HTLVIIB gp120 |
10/27/1998 | US5827719 Dna sequence isolated for saccharomyces cerevisiae dsm |
10/27/1998 | US5827717 Microorganisms their use and method of producing L-α-amino acids |
10/27/1998 | US5827713 Polynucleotide for gene expression of chondroitin 6-sulfotransferase (c6st) prepared from chick embryo chondrocytes |
10/27/1998 | US5827712 Culturing with a gene encoding a heat shock protein enhancing to produce a soluble transglutaminase |
10/27/1998 | US5827710 Obtained by plaque hybridization from dna library derived from avian heart muscle |
10/27/1998 | US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells |
10/27/1998 | US5827706 Nucleotide sequence which codes for cyclosporin synthetase and vectors containing the sequence |
10/27/1998 | US5827705 Molecule and method for importing DNA into a nucleus |
10/27/1998 | US5827704 Using vectors that allow double-stranded dna which has blunt or one-base 3' overhanging termini to be modified to produce dna fragments having any desired 5' overhang sequence, in reading frame of choice |
10/27/1998 | US5827703 Methods and composition for in vivo gene therapy |
10/27/1998 | US5827702 Contacting an ocular cell with exogenous nucleic acid under conditions permissive for it uptake and expression; genetic engineering |
10/27/1998 | US5827698 Lysine decarboxylase gene and method of producing l-lysine |
10/27/1998 | US5827696 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
10/27/1998 | US5827695 Detection of wheat fungal pathogens using the polymerase chain reaction |
10/27/1998 | US5827694 Bovine, porcine, feline, rabbit interferons |
10/27/1998 | US5827693 Expression of recombinant hemoglobin and hemoglobin variants in yeast |
10/27/1998 | US5827692 Parasiticides against heartworm, elephantiasis |
10/27/1998 | US5827691 Process for preparing a protein which inhibits metastasis of cancer |
10/27/1998 | US5827690 Transgenic production of antibodies in milk |
10/27/1998 | US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology |
10/27/1998 | US5827688 Secreted proteins and polynucleotides encoding them |
10/27/1998 | US5827687 Isolated dna linked to a gene coding for a protein which can be expressed in genetically engineered animal cells |
10/27/1998 | US5827686 Method of expressing genes in mammalian cells |
10/27/1998 | US5827685 Methods and compositions of genetic stress response systems |
10/27/1998 | US5827684 Production of Bacillus entomotoxins in methylotrophic yeast |
10/27/1998 | US5827683 Nucleic acids encoding BSSL variants |
10/27/1998 | US5827678 Assay reagent comprising killed bacterial cells which retain functional metabolic activity |
10/27/1998 | US5827671 Antibodies raised against proteins of Leishmania which are expressed at an increased level in the amastigote form |
10/27/1998 | US5827668 Immunodiagnostic assay for rheumatoid arthritis |
10/27/1998 | US5827662 Methods for detecting genetic mutations resulting in protease inhibitor insufficiencies |